Diagnosing Deep-vein Thrombosis Early in Critically Ill Patients
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorKing Abdullah International Medical Research Center
About this trial
The DETECT randomized controlled trial addresses the question of whether surveillance ultrasound in critically ill patients by facilitating DVT detection reduces the incidence of PE and lowers all-cause 90-day mortality. The primary outcome is 90-day all-cause mortality.
Eligibility criteria
Qualifiers
Medical, surgical or trauma ICU patients ≥18 years old.
Patients who are expected to stay in the ICU more than 2 calendar days (unlikely to be discharged out of ICU on the day of admission or on the next day).
Disqualifiers
Patients with DVT or PE diagnosed within the last year.
Patients receiving chronic systemic anticoagulation.
Patients who have received up to the time of ICU admission or are receiving therapeutic doses of anticoagulation with UFH, LMWH, or other anticoagulants.
Inability or contraindication to obtain adequate ultrasound on the lower extremities (Burns in the lower extremities, lacerations, active skin infection, & ischemic limb in the legs, large dressings in the thighs that prevent adequate ultrasounds OR amputated foot or leg on one or two sides)
Trial design
Treatments tested in this trial
- Proximal lower limb ultrasound
Treatment groups
1,800 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov